STUDY QUESTION: The aim of this study was to evaluate the live birth rate (LBR) after frozen-thawed Day 5 (D5) and Day 6 (D6) blastocyst transfers.
by Gardner) were transferred in the D5 group than in the D6 group [807 (81.2%) versus 214 (60.6%); P < 0.001]. However, a comparison of TBT cycles with equal embryo quality (good versus low) also supported the superiority of D5 blastocysts. Concerning neonatal outcomes, the D5 group infants had a lower mean birth weight compared to those of the D6 group (P = 0.001). In addition, a significantly shorter gestational age at birth is reported in the D5 blastocyst group as compared to the D6 group (P = 0.004). After multivariate logistic regression taking into account potential confounders such as the women's age, number of previous IVF/ICSI procedures, the day of the blastocyst vitrification (D5 or D6) and embryo quality, blastocyst expansion at D6 was independently associated with a significant decrease in LBR compared to D5 expanded-blastocysts (OR 0.52; 95% CI 0.38-0.72; P < 0.001).
Introduction
Improvements in terms of embryo culture conditions and the advent of vitrification as a revolutionary cryopreservation technique have allowed for widespread use of embryo transfer at the blastocyst stage (Liebermann and Tucker, 2006; Stanger et al., 2012; Rienzi et al., 2017) . Moreover, elective single blastocyst transfer allows more supernumerary embryos to be generated for cryopreservation.
On the other hand, it has been well established that ovarian stimulation leads to endometrial changes that result in deleterious effects on the implantation window. This negative impact is characterized by the presence of endometrial abnormalities and an advancement of endometrial development during IVF cycles, which in turn results in an accelerated closure of the implantation window (Kolibianakis and Devroey, 2002; Kolibianakis et al., 2003) . More recent studies have also revealed differences in gene expression showing that endometrial development is affected by ovarian stimulation (Horcajadas et al., 2008) . This could explain why several studies involving fresh blastocyst transfer have found higher pregnancy rates (PR) with Day-5 (D5) blastocysts compared with those developing on Day 6 (D6) (Khorram et al., 2000; Shapiro et al., 2001; Barrenetxea et al., 2005; El-Toukhy et al., 2011; Poulsen et al., 2017) .
Due to hormonal priming of endometrial receptivity, the same clinical outcomes should be expected with programmed thawed blastocyst transfer (TBT) cycles when transferring D5 or D6 blastocysts as a result of a better endometrial-embryonic synchronization. However, conflicting results are still persisting in regard to comparisons of pregnancy outcomes for D5 versus D6 TBT. Some studies have reported higher clinical PR after D5 frozen-TBT cycles as compared with D6 blastocysts (Liebermann and Tucker, 2006; Desai et al., 2016; Haas et al., 2016) . Other studies have reported that ART outcomes are similar for D5 and D6 cryopreserved blastocyst transfers (Behr et al., 2002; Levens et al., 2008; El-Toukhy et al., 2011; Wang et al., 2016; Kaye et al., 2017) .
All of these recent studies underscore the importance of this issue for optimizing the transfer of frozen blastocysts, while they also indicate that an embryonic factor probably underlies the observed difference between D5 and D6 TBT. Both embryo quality and endometrial receptivity are critical to implantation. The endometrium seems to play a major role because of its response and selective capacity to discriminate high and low embryo quality (Weimar et al., 2012) . The aim of this study was hence to compare live birth rates (LBR) and neonatal outcomes after TBT cycles with D5 versus D6 blastocysts.
Materials and Methods

Study design
We conducted a retrospective cohort follow-up study that included all single autologous frozen-TBT performed after ovarian stimulation between January 2012 and December 2015 in the ART unit at the university-based reproductive medicine center of our institution.
Two patient groups were compared according to the day of blastocyst expansion: (i) D5 blastocysts and (ii) D6 blastocysts. This study was approved by the National Data Protection Authority (Commission Nationale de l'Informatique et des Libertés, CNIL no. 1988293 v 0) on the 5 September 2016.
Patient cohort
During the study period, 2457 FET were performed. Blastocysts originated from: (i) supernumerary embryos kept in prolonged culture after fresh D2 embryo transfer and (ii) 'freeze all' strategy cycles. For both groups, inclusion criteria included the following items: a requirement for ART with IVF or ICSI, being ≤42 years of age, and undergoing a single autologous frozen-TBT. Exclusion criteria were: canceled embryo transfers, vitrified oocyte procedures, donor cycles, simultaneous D5-D6 double embryo transfers, D2 frozen embryo transfers, natural endometrial preparation and GnRH agonist pretreatment.
Fertilization methods and embryo culture and scoring
Conventional IVF or ICSI was performed as appropriate based on the presence or absence of male factor infertility. Embryos were cultured individually in 50 μl of Global medium droplets (Global, LifeGlobal, USA) under mineral oil (Origio, Denmark) and incubated in an atmosphere of 5.5% CO 2 , 5% O 2 and 89.5% N 2 . Fertilization was assessed 16-18 h post insemination/injection and an embryo quality assessment was performed on D2 (if it involved a fresh cleaved embryo transfer) as well as on D5 and D6. After fresh embryo transfer on D2, all of the supernumerary embryos were cultured until Day 5 or Day 6, regardless of their quality. For the freeze-all cycles, embryos were maintained in extended culture after assessment of fertilization on Day-1.
At the blastocyst stage, embryo quality was assessed on D5 and D6 according to the Gardner classification, which takes into account the expansion grade as well as the development of the inner cell mass (ICM) and the trophectoderm (TE) (Gardner et al., 1998) . Based on this classification, only expanded top (B3 AA, B4 AA and B5 AA), good (B3 AB/BA, B4 AB/BA and B5 AB/BA) and fair (B3 AC/BC/CA/CB, B4 AC/BC/ CA/CB and B5 AC/BC/CA/CB) quality Day 5/6 blastocysts were selected for cryopreservation by vitrification while poor-quality blastocysts (B3 CC, B4 CC and B5 CC) were excluded and destroyed. B1 and two blastocysts on Day 5 were evaluated on Day 6 and cryopreserved only if they were expanded.
Blastocyst vitrification and thawing procedures
Blastocyst vitrification was performed using closed CBS-VIT High Security (HS) straws (Cryo Bio System, France) in combination with DMSO-EG-S as the cryoprotectants (Irvine Scientific © Freeze Kit, USA). The first step of the vitrification procedure consisted of exposing the embryos to cryoprotectants, and it was carried out at room temperature (i.e. between 20 and 23°C). Each blastocyst was first incubated for 1 min in a 50 μl droplet of HEPES-buffered culture medium. It was then transferred into two 50 μl droplets of diluted equilibration solution (ES) containing 7.5% (v/v) DMSO and 7.5% (v/v) ethylene glycol, and incubated for 2 min in each droplet before being transferred into a third 50 μl droplet of ES solution and incubated for a further 10 min. The blastocyst was then transferred consecutively into four 25 μl droplets of vitrification solution (VS) containing 15% (v/v) DMSO, 15% (v/v) ethylene glycol and 0.5 M sucrose. It was then transferred into the fourth droplet, and immediately loaded onto the CBS-HS straw. Each straw containing one blastocyst was then sealed and plunged into liquid nitrogen. On the day of the embryo transfer, the blastocyst with the highest score was selected before thawing and transfer. The choice of the embryo to transfer was not based on the day of expansion but exclusively dependent on its quality according to Gardner scoring. The blastocyst was thawed using an Irvine Scientific Thaw Kit (Irvine Scientific © Thaw Kit, USA). A Petri dish containing one 300 μl droplet of thawing solution (TS: 1.0 M sucrose in HEPES-buffered HTF medium) was maintained at 37°C. The straw was transferred from the liquid nitrogen storage container to a transport Dewar filled with liquid nitrogen. After cutting the straw and pulling out the capillary from the straw, the gutter was immediately placed in the droplet with TS, allowing the blastocyst to be released from the gutter and maintained at 37°C for 1 min. The blastocyst was then incubated twice for 1 min at room temperature in two 50 μl TS droplets. After this, the blastocyst was transferred to the first of two 50 μl dilution solution droplets (DS: 0.5 M sucrose in Hepes-buffered HTF medium) followed by a 2 min incubation in a second DS droplet. Finally, the blastocyst was washed in three droplets (50 μl each) of wash solution (Hepes-buffered HTF medium) for 3 min. The blastocyst was then transferred into a Global (Global, LifeGlobal, USA) culture medium droplet in a culture dish. After warming, blastocyst quality can be evaluated when re-expansion occurs, in which case the quality is always the same as before vitrification. In case of ICM and/or trophectoderm lysis, the blastocyst is discarded and another one is warmed. After survival assessment, the blastocyst was maintained in an incubator before intrauterine transfer 2-4 h hours later under ultrasound guidance.
Endometrial programming prior to embryo transfer
The women received an estradiol (E2) priming regimen that was delivered transdermally (0.2 mg/day, simultaneously through two Vivelledot ® 100
systems, Novartis Pharma SA, Rueil Malmaison, France) or orally (8 mg/ day, Provames ® , Sanofi Aventis, Paris, France). The patients were examined after menstruation in order to assess their endometrial thickness and to determine their progesterone levels. When conditions were deemed to be appropriate (e.g. endometrium thickness ≥6 mm and progesterone <1.5 ng/ml), embryo transfer was performed on the fifth day of the progesterone exposure. Vaginal progesterone treatment was initiated at a dose of 200 mg three times per day. In case of pregnancy, progesterone and E2 treatment was maintained at the same doses until 12 weeks of gestation. In case of inadequate endometrial thickness or progesterone levels higher than 1.5 ng/ml, the embryo transfer was canceled and postponed to another cycle.
Observational indicators and main cycle outcomes
The general characteristics of the patients in both groups were recorded prospectively during their medical consultations. The following data were collected: age (in years), height (in meters), weight (in kilograms), IVF/ICSI rank, type of infertility, (BMI (calculated as weight (kg)/[height (m)] 2 ), smoking habits, ovarian reserve D3 FSH, antral follicle count (AFC), AMH levels and infertility cause(s) (e.g. ovulation disorder, male factor, tubal factor, endometriosis, premature ovarian failure (POF) or idiopathic).
The primary outcome was the presence of a live birth, which was defined as delivery of a viable infant at ≥28 weeks of gestation after embryo transfer (Chen et al., 2016) . Secondary outcomes included clinical pregnancy rate (cPR), early miscarriage rate, and neonatal outcomes. cPR was determined by ultrasonographic documentation of at least one fetus with a heartbeat at 6-7 weeks of gestation (Zegers-Hochschild et al., 2009) . Early miscarriage was defined as an intrauterine pregnancy loss before 10 weeks of gestation (Kolte et al., 2015) . The neonatal outcomes were: gestational age at delivery, preterm birth (<37 weeks) and postterm birth (≥41 weeks), low birth weight (<2500 g) and high birth weight (≥4000 g) (Declercq et al., 2015) .
Statistical analysis
All data were compiled into a digital database and analyzed using SPSS software (SPSS Inc., Chicago, IL, USA). A P-value < 0.05 was considered to be statistically significant. For univariate statistical analysis, we used the following tests: Pearson's χ2 test or Fisher's exact test for qualitative variables, or Student's t-test or the Mann-Whitney test for quantitative variables, as appropriate. To identify potential confounding variables that could be independently associated with live birth, we performed a logistic regression analysis. Potential confounding factors were tested by univariate analysis, and added in a multiple logistic regression model. Patient age (>35 y/o), IVF/ICSI rank, embryo quality and the day of blastocyst expansion (D5 versus D6) were included in the multiple logistic regression model. Backward stepwise selection was used to retain variables with a P-value of <0.05 in each final model. The parameter values for each of the final models were estimated by the maximum likelihood method. In case of significant differences, odds ratios (OR) and their 95% confidence intervals (95% CI) were calculated from the model's coefficients and their standard deviations.
Results
Study population
The process of our cohort selection is detailed in Fig. 1 . Of the initial cohort of 2457 FET performed in our reproductive medicine unit during the study period, 1056 FET were excluded from the study for the following reasons: FET performed at D2 (n = 986), embryo donation (n = 41), embryos derived from vitrified oocytes (n = 10), FET performed in a natural endometrium preparation (n = 4) and women who underwent GnRH agonist pretreatment prior to FET (n = 15). Also excluded were 54 blastocyst embryo transfers due to missing data (e.g. unknown date of the last menstruation, day of the blastocyst expansion) (n = 44) or because they were lost to follow-up (n = 10). Overall, 1347 blastocyst embryo transfers were analyzed in this study. The women were allocated to one of the two groups based on the day of the blastocyst expansion. We analyzed 994 TBT in the D5 group and 353 in the D6 group.
Baseline characteristics
Patient characteristics at the time of the first warming cycle are presented in Table I . The mean BMI, the number of patients >35 years of age, and the patients' ovarian reserves did not differ between the two groups. There were no differences either in regard to the type of estradiol treatment during the endometrial preparation (P = 0.364). The mean endometrial thickness on the first day of the progesterone administration was similar for the two groups (8.96 ± 1.82 versus 8.93 ± 1.87; P = 0.856). A higher proportion of good-quality blastocysts were transferred after warming in the D5 (81.2%) compared with those in the D6 group (68.3%) (P < 0.001) while the overall survival rate was 95% in the Day-5 and Day-6 groups. 
ART and neonatal outcomes
The LBR was significantly higher for the D5 group compared to the D6 group [294/994 (29.6%) versus 60/353 (17.0%); P < 0.001] ( Table II) (Table II) . Regarding the neonatal outcomes, infants of the D5 group had a lower mean birth weight compared to those of the D6 group (3336.05 g ± 605.47 versus 3543.66 g ± 458.24; P = 0.001). In addition, a significantly lower gestational age at birth was reported for the D5 blastocyst group (274.66 days ± 19.70 versus 280.89 days ± 10.21; P = 0.004). Figure 2 describes LBR according to embryo quality among D5 and D6 blastocyst groups. LBR is significantly higher superior in D5 group, in both good (31.0 versus 18,7%; P < 0.001) and low (23.5 versus 13.4%; P = 0.033) quality blastocysts (see also Supplementary Tables SI and SII).
Multivariate analysis
A multivariate analysis was performed to adjust for potentially confounding factors: the women's age (>35 y/o), the number of previous IVF/ICSI procedures, the day of the blastocyst expansion (D5 or D6) and the embryo quality (Table III) .
The following variables were found to be independently associated with the LBR: blastocyst expansion at D6 was independently associated with a significant decrease in the LBR compared to D5 blastocyst expansion (OR = 0.52; 95% CI: [0.38-0.72]; P < 0.001), as well as women's age at the time of the oocyte retrieval (>35 y/o) and having a previous history of IVF/ICSI attempt (OR = 0.71; 95% CI: [0.55-0.92]; P = 0.01 and OR = 0.71; 95% CI: [0.52-0.97]; P = 0.03, respectively). Conversely, a good-quality embryo transfer (≥3BB) had a significant positive impact on the LBR (OR = 1.52; 95% CI: [1.04-2.23]; P = 0.03).
Discussion
The results of this large cohort study allowed us to conclude that expanded blastocysts at D5 had a higher chance of successful gestation and delivery than D6 blastocysts after TBT. Our findings confirm the hypothesis that the differences observed after TBT cycles with D5 and D6 blastocysts could be due at least partially to impaired embryo quality. Both embryo quality and endometrial receptivity are critical to implantation. The role of the endometrium has been said to be of greater significance, because of its response and selective capacity A good-quality embryo was defined as a B3-B4 or B5 embryo ≥ BB (AA, AB, BA, BB) according to the grading scale proposed by Gardner. (Weimar et al., 2012) . In this study we do not dispute the crucial role of endometrial receptivity in the complex process of human embryo implantation. However, in our study, we were able to confirm that significant differences in reproductive potential exists between D5 and D6 blastocyst, as both were transferred in artificial hormonal preparation TBT cycles that promotes better embryo: endometrium synchrony, therefore, eliminating any endometrial receptivity bias.
Our results are consistent with those reported by Haas et al. The authors reported a significantly lower pregnancy rate from frozen embryo transfer cycles with D6 vitrified blastocysts, even when they were deemed to be good-quality embryos by morphological assessment, as compared to blastocysts vitrified on Day 5 (Haas et al., 2016) .
However, the same team has acknowledged a number of limitations in regard to their study, such as the day of the blastocyst thawing. Indeed, they thawed the vitrified D5 blastocysts 20-24 h prior to the embryo transfer, while they thawed the D6 blastocysts 2-4 h prior to the transfer. This differs from our protocol in which both D5 and D6 blastocysts were warmed 2-4 h before embryo transfer. In our study, the LBR of 17% observed in the D6 group seems to be low when compared to literature data. According to some authors, such a low LBR is associated with poor prognosis patients (Drakopoulos et al., 2016) . However, in our study, the patient characteristics were similar in the two groups; the observed LBR was only dependent on the day of blastocyst expansion.
There is still a degree of controversy in the literature in this regard. According to some authors, slow growing blastocysts with delayed expansion at D6 have no impact on PR, provided that only goodquality embryos are transferred (Sunkara et al., 2010; El-Toukhy et al., 2011; Capalbo et al., 2014; Yang et al., 2016) . In Yang's study, the PRs were similar between D5 and D6 group when only high-quality blastocysts were considered . These results are in line with those reported in the meta-analysis performed by Sunkara et al. that included 15 studies together including 2502 frozen-TBT. No differences in ongoing pregnancy and LBR were noted after D5-TBT versus D6-TBT with the same morphological blastocyst quality on the day of the cryopreservation. The same authors reported a significant increase in the PR with D5 vitrified-TBT compared with D6 vitrified-TBT whatever their quality (Sunkara et al., 2010) .
In keeping with reports in the literature, our data indicate that embryo quality is positively associated with achieving pregnancy in IVF programs (Gardner, 2000; Ahlström et al., 2011; Van den Abbeel et al., 2013) . Indeed, after multivariate logistic regression, the day of blastocyst expansion and a good-quality embryo (≥3BB) independently and significantly associated in a positive manner with the LBR. Comparison of FET cycles with equal quality blastocysts was performed and pregnancy outcomes for low-quality (<BB) or good-quality (≥3BB) frozen TBT (Fig. 2) and Day 6 blastocyst transfer (Green) according to embryo quality: Good quality and low quality embryo transfer. A good-quality embryo was defined as a B3-B4 or B5 embryo ≥ BB (AA, AB, BA, BB) according to the grading scale proposed by Gardner. A low-quality embryo was defined as a B3-B4 or B5 embryo < BB (BC, CB, AC, CA) according to the grading scale proposed by Gardner. *P < 0.05.
Chromosomal factor
We did not perform pre-implantation genetic screening in our study but chromosomal abnormalities could conceivably explain the difference in clinical outcomes between the two groups. Indeed, a higher aneuploidy rate has been reported in slower developing blastocysts (Alfarawati et al., 2011; Taylor et al., 2014) , with Taylor et al. speculating that the 10% increase in aneuploidy rates in embryos that blastulate on D6 might be the reason for the lower pregnancy and LBR after D6 TBT. Regardless of the day of blastocyst expansion, embryo morphology was also considered as a predictive factor of blastocyst chromosomal status. Indeed, Capalbo et al. (2014) showed that the euploidy rate of blastocysts with high-quality morphology was significantly higher compared with those that had poor-quality morphology. However, these findings remain controversial. Thus, in Yang's study, no difference in euploidy rate and PR between high-quality D5 and D6 blastocysts after frozen-thawed transfer cycles was reported . In the same vein, Kroener et al. (2012) found no differences in aneuploidy rates, irrespective of the day of blastulation, while the absence of blastulation was associated with increased aneuploidy. Alfarawati et al. (2011) similarly showed that delayed blastulation was not associated with increased aneuploidy.
Neonatal outcomes
In our study, newborns from the D5 group weighed less compared to newborns from the D6 group (P = 0.001). Data from animal and human studies have suggested that extended culture leads to heavier newborns. In the study by Zhu et al. (2014) newborn birthweights from fresh D3 embryo transfers were significantly lower than after D5/6 blastocyst transfers. In our study, only one more day of embryo culture generated a mean birth weight difference of 200 g while extreme newborn weights were equivalent between D5 and D6. In accordance with our results, Wang et al. (2016) reported heavier newborns after D6 blastocyst transfer compared to D5, although the difference was not significant. These reports indicate that there could be an impact of the day of blastocyst expansion on placentation and fetal growth. Changes in fetal development, especially a birth weight normalization in the third trimester, have been suggested to be a compensatory reaction to poor placentation (Wennerholm et al., 2013; Ozgur et al., 2015) . However, additional information would be required to adequately confirm these findings. There is a high level of heterogeneity between the various studies, particularly in terms of culture media composition, embryo cryopreservation methods, and the stage of embryo transfer, as well as endometrium preparation. Finally, the increase in birthweights in the D6 group reported in our study could be also explained by an increase in the length of gestation. In light of this, any comparison of the data from these various studies should be undertaken with a significant degree of caution.
Conclusion
We compared the LBR and neonatal outcomes after frozen-thawed D5 and D6 blastocyst transfers. We found that embryos reaching the expanded blastocyst stage at D5 had significantly higher chances of leading to a live birth than those at D6 stage. Our results indicate that the day of the blastocyst expansion and the blastocyst morphology need to be given full consideration when selecting the best embryo to transfer during TBT cycles, as it would appear that blastocysts cryopreserved on D5 may be the preferred choice. Therefore, our study confirmed the assumption that this difference is related to an embryo quality impairment, rather than an endometrial factor. Further studies are needed, however, to confirm these results. The number of previous IVF/ICSI cycles is defined as the number of previous controlled ovarian stimulations leading to at least one embryo transfer with no pregnancy being obtained.
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